Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Narrows Net Loss in Fiscal Q1 Though Revenues Inch Down

NEW YORK (GenomeWeb News) – Accelrys reported its fiscal year 2007 first quarter results today and said its net loss shrank 83 percent.
 
Receipts for the three months ended June 30 inched down to $20.1 million, from $20.4 million year over year. The company said the decline is the result of fluctuations in foreign currency exchange rates.
 
Product development costs also declined 12 percent, to $5.1 million from $5.8 million from the comparable quarter a year ago.
 
Accelrys said net loss narrowed to $329,000 for the first quarter compared to $1.9 million last year.
 
Accelrys had $63 million in cash and cash equivalents as of June 30.
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.